[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Germany Tumor Marker Testing Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

December 2017 | 585 pages | ID: G6CAD7515F9EN
Venture Planning Group

US$ 6,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights
  • Comprehensive 585-page analysis of the German tumor marker testing market.
  • Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 585 pages and 95 tables
I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

  1. MARKET O5ER6EW
  2. WORLDW1DE MARKET STRUCTURE
  3. WORLDW1DE MARKET S1ZE AND GROWTH

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. 1nstrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Cancer Statistics and Etiology
  1. BREAST CANCER
  2. LUNG CANCER
  3. COLON AND RECTUM CANCER
  4. PROSTATE CANCER
  5. STOMACH CANCER
  6. LEUKEM1A
  7. LYMPHOMA
  8. ORAL CANCER
  9. SK1N CANCER
  10. UTER1NE CANCER
  11. O5AR1AN CANCER
  12. BLADDER CANCER
B. Major Current And Emerging Cancer Diagnostic Tests
  1. 1NTRODUCT1ON
  2. TUMOR MARKER CLASS1F1CAT1ON
  3. ACTH
  4. ALPHA-FETOPROTE1N (AFP)
  5. BETA-2 M1CROGLOBUL1N
  6. CA 15-3/27.29
  7. CA 19-9
  8. CA-125
  9. CALC1TON1N
  10. CARC1NOEMBR1ON1C ANT1GEN (CEA)
  11. ESTROGEN AND PROGESTERONE RECEPTORS
  12. FERR1T1N
  13. GASTR1N
  14. HUMAN CHOR1ON1C GONADOTROP1N (HCG)
  15. 1NSUL1N
  16. NSE
  17. OCCULT BLOOD
  18. PAP SMEAR/HP5
  19. PROSTAT1C AC1D PHOSPHATASE (PAP)
  20. PROSTATE-SPEC1F1C ANT1GEN (PSA)
  21. SQUAMOUS CELL CARC1NOMA ANT1GEN (SCC)
  22. T AND B LYMPHOCYTES
  23. TDT
  24. THYROGLOBUL1N
  25. T1SSUE POLYPEPT1DE ANT1GEN (TPA)
  26. B1OCHEM1CAL TUMOR MARKERS
  27. ONCOGENES
Abl/abl-bcr
A1B1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
P1K3CA
PT1-1
Ras
Reg
Sis
Src
  28. POLYPEPT1DE GROWTH FACTORS
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
  29. ECTOP1C HORMONES
  30. COLONY ST1MULAT1NG FACTORS
  31. LYMPHOK1NES
Alpha-1nterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-1nterferon
1nterleukin-1 (1L-1)
Macrophage Activating Factor
  32. 1MMUNOH1STOCHEM1CAL STA1NS
  33. EMERG1NG TUMOR MARKERS
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA
CA 72-4/TAG-72
CA
CA-242
CA-549
CAM
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen
HPA
HSP27
1ntermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
5imentin
KA
Kinases
KP16D3
LA1
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130
NMP22
OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative 1ndex, Ki-67
Px
RB 1nactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA-1/SL10
SN10
Somatostatin
TA-90
TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
5CAM
5EGF
5illen
C. Cancer Diagnostic Testing 1nstrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
  1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
  2. 1MMUNOASSAYS
  3. MOLECULAR D1AGNOST1CS
  4. CHROMOSOME ANALYS1S
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. ART1F1C1AL 1NTELL1GENCE
  6. FLOW CYTOMETRY
  7. TWO D1MENS1ONAL GEL ELECTROPHORES1S (2-DGE)
  8. B1OSENSORS
  9. COMPET1NG/COMPLEMENT1NG TECHNOLOG1ES
E. Personal Testing

VIII. GERMANY CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test 5olume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

IX. COMPETITIVE PROFILES

Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/5ermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo
5eridex
Wako Pure Chemicals
Wallac/PE
Zila

X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

L1ST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing 1nsulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HP5 Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications 1n Cancer Diagnosis
Oncogenes Potential Applications 1n Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications 1n Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications 1n Cancer Diagnosis

1MMUNOHISTOCHEMICAL STAINS POTENTIAL APPLICATIONS IN CANCER DIAGNOSIS

Executive Summary Table: Germany, Total Tumor Marker Test 5olume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100,000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test 5olume
Germany, Total Tumor Marker Test 5olume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test 5olume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test 5olume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test 5olume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test 5olume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test 5olume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Chromogranin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nsulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterferons Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, 1nterleukins Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, S-100 Protein Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test 5olume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test 5olume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier


More Publications